Understanding how Factor XII affects complications in sickle cell disease
Role of Factor XII in Thrombo-Inflammatory Complications of Sickle Cell Disease
['FUNDING_R01'] · UNIV OF NORTH CAROLINA CHAPEL HILL · NIH-10859580
This study is looking at how a protein called Factor XII affects sickle cell disease and its complications, like blood clots and painful crises, to see if a special treatment can help reduce these issues for people living with the condition.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIV OF NORTH CAROLINA CHAPEL HILL (nih funded) |
| Locations | 1 site (CHAPEL HILL, UNITED STATES) |
| Trial ID | NIH-10859580 on ClinicalTrials.gov |
What this research studies
This research investigates the role of Factor XII in sickle cell disease (SCD) and how it contributes to complications such as venous thrombosis and vaso-occlusive crises. The study aims to characterize the functions of Factor XII and its impact on neutrophil activation and adhesion, which are critical in the disease's progression. By exploring the effects of an anti-FXII antibody that blocks its functions, the research seeks to identify potential new therapies that could reduce complications associated with SCD.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with sickle cell disease who experience recurrent vaso-occlusive crises or venous thrombosis.
Not a fit: Patients without a diagnosis of sickle cell disease or those who do not experience thrombo-inflammatory complications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly reduce the painful complications and organ damage associated with sickle cell disease.
How similar studies have performed: Previous studies have shown promising results in targeting Factor XII for therapeutic purposes, indicating that this approach may lead to significant advancements in treatment.
Where this research is happening
CHAPEL HILL, UNITED STATES
- UNIV OF NORTH CAROLINA CHAPEL HILL — CHAPEL HILL, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PAWLINSKI, RAFAL L — UNIV OF NORTH CAROLINA CHAPEL HILL
- Study coordinator: PAWLINSKI, RAFAL L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.